315
Views
11
CrossRef citations to date
0
Altmetric
Original Article: Research

Widespread use of complementary and alternative medicine among non-Hodgkin lymphoma survivors

, , , , , , , , , , & show all
Pages 434-439 | Received 18 Feb 2014, Accepted 16 Apr 2014, Published online: 27 Jun 2014

References

  • Cancer Treatment and Survivorship Facts and Figures 2012–2013. Atlanta: American Cancer Society; 2012.
  • Oeffinger KC, McCabe MS. Models for delivering survivorship care. J Clin Oncol 2006;24:5117–5124.
  • Rausch SM, Winegardner F, Kruk KM, et al. Complementary and alternative medicine: use and disclosure in radiation oncology community practice. Support Care Cancer 2011;19:521–529.
  • Richardson MA, Sanders T, Palmer JL, et al. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000;18:2505–2514.
  • Richardson MA, Straus SE. Complementary and alternative medicine: opportunities and challenges for cancer management and research. Semin Oncol 2002;29:531–545.
  • Dy GK, Bekele L, Hanson LJ, et al. Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. J Clin Oncol 2004;22:4810–4815.
  • Yates JS, Mustian KM, Morrow GR, et al. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer 2005;13:806–811.
  • Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 2008:1–23.
  • Habermann TM, Thompson CA, LaPlant BR, et al. Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study. Am J Hematol 2009;84:795–798.
  • Molassiotis A, Yung HP, Yam BM, et al. The effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese breast cancer patients: a randomised controlled trial. Support Care Cancer 2002;10:237–246.
  • Sahler OJ, Hunter BC, Liesveld JL. The effect of using music therapy with relaxation imagery in the management of patients undergoing bone marrow transplantation: a pilot feasibility study. Altern Ther Health Med 2003;9:70–74.
  • Syrjala KL, Donaldson GW, Davis MW, et al. Relaxation and imagery and cognitive-behavioral training reduce pain during cancer treatment: a controlled clinical trial. Pain 1995;63:189–198.
  • Jarden M, Hovgaard D, Boesen E, et al. Pilot study of a multimodal intervention: mixed-type exercise and psychoeducation in patients undergoing allogeneic stem cell transplantation. Bone Marrow Transplant 2007;40:793–800.
  • Horton-Deutsch S, O’Haver Day P, Haight R, et al. Enhancing mental health services to bone marrow transplant recipients through a mindfulness-based therapeutic intervention. Complement Ther Clin Pract 2007;13:110–115.
  • Holland JC, Morrow GR, Schmale A, et al. A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. J Clin Oncol 1991;9:1004–1011.
  • Kim SD, Kim HS. Effects of a relaxation breathing exercise on fatigue in haemopoietic stem cell transplantation patients. J Clin Nurs 2005;14:51–55.
  • Cohen L, Warneke C, Fouladi RT, et al. Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer 2004;100: 2253–2260.
  • Hardy ML. Dietary supplement use in cancer care: help or harm. Hematol Oncol Clin North Am 2008;22:581–617, vii.
  • Skalli S, Zaid A, Soulaymani R. Drug interactions with herbal medicines. Ther Drug Monit 2007;29:679–686.
  • Werneke U, Earl J, Seydel C, et al. Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer 2004;90:408–413.
  • Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998;280:1569–1575.
  • Gupta D, Lis CG, Birdsall TC, et al. The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care. Support Care Cancer 2005;13:912–919.
  • Hann DM, Baker F, Roberts CS, et al. Use of complementary therapies among breast and prostate cancer patients during treatment: a multisite study. Integr Cancer Ther 2005;4:294–300.
  • Hensel M, Zoz M, Ho AD. Complementary and alternative medicine in patients with chronic lymphocytic leukemia. Support Care Cancer 2009;17:47–52.
  • Drake MT, Maurer MJ, Link BK, et al. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J Clin Oncol 2010;28:4191–4198.
  • Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.
  • Yates P. Towards a reconceptualization of hope for patients with a diagnosis of cancer. J Adv Nurs 1993;18:701–706.
  • Molassiotis A, Margulies A, Fernandez-Ortega P, et al. Complementary and alternative medicine use in patients with haematological malignancies in Europe. Complement Ther Clin Pract 2005;11:105–110.
  • D’Arena G, Laurenti L, Coscia M, et al. Complementary and alternative medicine use in patients with chronic lymphocytic Leukemia: an Italian multicentric survey. Leuk Lymphoma 2014;55: 841–847.
  • Spadacio C, Barros NF. [Use of complementary and alternative medicine by cancer patients: systematic review]. Rev Saude Publica 2008;42:158–164.
  • Broom A, Wijewardena K, Sibbritt D, et al. The use of traditional, complementary and alternative medicine in Sri Lankan cancer care: results from a survey of 500 cancer patients. Public Health 2010;124: 232–237.
  • Gupta M, Shafiq N, Kumari S, et al. Patterns and perceptions of complementary and alternative medicine (CAM) among leukaemia patients visiting haematology clinic of a north Indian tertiary care hospital. Pharmacoepidemiol Drug Saf 2002;11:671–676.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.